Answers are grounded in this paper and cite their sources.
demonstrates subnanomolar cellular potency, high selectivity over other integrins, and favorable rodent pharmacokinetics following inhalation dosing. These attributes support its potential as a once-daily inhaled therapy for asthma. Collectively, our results establish selective α5β1 inhibition by inhalation as a novel approach to reduce ASM tension through the disruption of cellular tethering.
No takes yet. Share an insight, caveat, or question.
Beresis et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: